Mayra Hurtado knows the struggles of perimenopause first-hand. “My weight fluctuated so much, I had migraines and I literally saw every doctor,” she recalls. It was only after she visited a ...

Women are often described as “complicated”. It is a phrase people throw around casually. Mood swings. Fatigue. Irritability. Stress. These are often brushed off as personality traits or emotional ...

Bonsack is a patient advocate based in Moab, Utah. In the midst of a health crisis a few years ago, doctors repeatedly checked my thyroid-stimulating hormone (TSH), revealing an odd pattern: My test ...

At-home hormone tracking company Mira is partnering with ring maker Oura to connect hormone data with wellness data. Mira offers at-home tests, including a finger-prick test to measure hormones, ...

In transition-age patients with childhood-onset growth hormone deficiency (GHD), peak growth hormone (GH) response to the glucagon stimulation test (GST) appeared to be influenced more by the severity ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

The pad is meant to help people measure their follicle-stimulating hormone levels. The pad is meant to help people measure their follicle-stimulating hormone levels. is a senior reporter and author of ...

Built on nearly a decade of real-world hormone data, Mira's Hormone Monitor lays the foundation for a future home lab for longevity, metabolic health, and proactive care SAN FRANCISCO and LAS VEGAS, ...

Vivoo introduced a smart menstrual pad at CES. It turns period blood into data insights. The health company also launched its smart toilet sensor. The next generation of health wearables isn't wrapped ...

Rats with naturally high stress levels were far more likely to self-administer cannabis when given access. Behavioral testing showed that baseline stress hormones were the strongest predictor of ...

Fertility startup Inito has raised $29 million in Series B funding to scale its at-home health diagnostics platform and use AI-designed antibodies to unlock new kinds of at-home tests. When the ...